GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Ren | decreases expression | EXP | | 6480464 | CTD | Atenolol results in decreased expression of REN protein | PMID:9300315 | Ren | multiple interactions | EXP | | 6480464 | CTD | Atenolol inhibits the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in increased expression of REN protein]; Atenolol inhibits the reaction [2-hexynyladenosine-5'-N-ethylcarboxamide results in increased expression of REN protein] | PMID:9300315 | Ren | decreases activity | ISO | REN (Homo sapiens) | 6480464 | CTD | Atenolol results in decreased activity of REN protein | PMID:18957387 PMID:3333524 | Ren | decreases expression | ISO | REN (Homo sapiens) | 6480464 | CTD | Atenolol results in decreased expression of REN protein | PMID:14639093 | Ren | multiple interactions | ISO | REN (Homo sapiens) | 6480464 | CTD | [aliskiren co-treated with Atenolol] results in decreased activity of REN protein; [Dexamethasone co-treated with Nifedipine co-treated with Atenolol co-treated with Antihypertensive Agents] results in increased secretion of REN protein | PMID:18957387 PMID:3142437 | |
Go Back to source page | Continue to Ontology report |